Xolair 75 mg/0.5 ml
Xolair 75 mg/0.5 ml is a medicine authorised by Swissmedic under authorisation number 69272. The authorisation holder is Novartis Pharma Schweiz AG. The medicinal product code is Biotechnological medicines and the dispensing category is B: Supplied only against a prescription which, at the prescriber's discretion, may be dispensed repeatedly. First authorisation was granted on 03 July 2024 and the authorisation is limited until 02 July 2029. ATC code R03DX05 places the medicine in the group Drugs for obstructive airway diseases.
| Authorisation number | 69272 |
|---|---|
| Name | Xolair 75 mg/0.5 ml |
| Full name | Xolair 75 mg/0.5 ml, Injektionslösung in einem Fertigpen |
| Authorisation holder | Novartis Pharma Schweiz AG |
| Medicinal product code | Biotechnological medicines |
| Dispensing category | B · Prescription only |
| ATC code | R03DX05 |
| First authorisation | 03 July 2024 |
| Authorisation validity | 02 July 2029 |
| No. | Name | Dispensing category | Authorisation date |
|---|---|---|---|
| 1 | Xolair 75 mg/0.5 ml, Injektionslösung in einem Fertigpen | B | 03 July 2024 |
| 2 | Xolair 150 mg/1.0 ml, Injektionslösung in einem Fertigpen | B | 03 July 2024 |
| 3 | Xolair 300 mg/2.0 ml, Injektionslösung in einem Fertigpen | B | 03 July 2024 |
Scroll the table sideways
| Pack code | Quantity | Unit | ATC | IT code | Dispensing category |
|---|---|---|---|---|---|
| 1 | 1 | Injektor(en), vorgefüllt/Pen | R03DX05 | 03.04.5. | B |
| 2 | 1 | Injektor(en), vorgefüllt/Pen | R03DX05 | 03.04.5. | B |
| 3 | 1 | Injektor(en), vorgefüllt/Pen | R03DX05 | 03.04.5. | B |
Scroll the table sideways
Medicines in the same ATC group
Other medicines from this authorisation holder
Frequently asked questions
Is Xolair 75 mg/0.5 ml authorised in Switzerland?
Yes. Xolair 75 mg/0.5 ml is authorised by Swissmedic under authorisation number 69272, data as of 01 September 2026. The authorisation is limited until 02 July 2029.
Which dispensing category does Xolair 75 mg/0.5 ml have?
Xolair 75 mg/0.5 ml is in dispensing category B. Supplied only against a prescription which, at the prescriber's discretion, may be dispensed repeatedly.
Who is the authorisation holder of Xolair 75 mg/0.5 ml?
The authorisation holder is Novartis Pharma Schweiz AG. The holder carries the legal responsibility for quality, safety and product information of the medicine in Switzerland.
Sources
Swissmedic data as of 01 September 2026. No medical advice. Independent directory, not affiliated with Swissmedic or the FOPH.